DCZ

2'-DEOXYCYTIDINE

Created:	2001-05-30
Last modified:	2017-07-13

Find Related PDB Entry
14 entries where DCZ is found as a standalone ligand1 entries where DCZ is covalently linked to polymer or other heterogen groups 15 entries where DCZ is found in a polymer sequence

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	3
Bond Count	30
Aromatic Bond Count	0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2'-DEOXYCYTIDINE
Systematic Name (OpenEye OEToolkits)	4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
Formula	C₉ H₁₃ N₃ O₄
Molecular Weight	227.217
Type	DNA OH 5 PRIME TERMINUS

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C1N=C(N)C=CN1C2OC(C(O)C2)CO
SMILES	CACTVS	3.341	NC1=NC(=O)N(C=C1)[CH]2C[CH](O)[CH](CO)O2
SMILES	OpenEye OEToolkits	1.5.0	C1C(C(OC1N2C=CC(=NC2=O)N)CO)O
Canonical SMILES	CACTVS	3.341	NC1=NC(=O)N(C=C1)[C@H]2C[C@H](O)[C@@H](CO)O2
Canonical SMILES	OpenEye OEToolkits	1.5.0	C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O
InChI	InChI	1.03	InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1
InChIKey	InChI	1.03	CKTSBUTUHBMZGZ-SHYZEUOFSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB02594
Name	Doxecitine
Groups	investigational approved
Description	Doxecitine is a synthetic form of the naturally occurring pyrimidine deoxyribonucleoside deoxycytidine. It is an essential component of the deoxyribonucleotide pool required for DNA synthesis and repair. Doxecitine is currently approved and marketed as a fixed-dose combination therapy with [thymidine] (KYGEVVI). This combination is the first and only approved treatment for Thymidine Kinase 2 deficiency.[L54613, L54618]
Synonyms	1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine dC MT-1621 COMPONENT 2'-DEOXYCYTIDINE 2'-Deoxycytidine Doxecitine Deoxyribose cytidine 4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone CYTIDINE, 2'-DEOXY- DEOXYCYTIDINE 1-(2-Deoxy-β-D-ribofuranosyl)cytosine 4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2- yl)pyrimidin-2(1H)-one dCYD 4-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone 2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-
Indication	In combination with [thymidine], doxecitine is indicated for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years.[L54541]
Categories	Deoxycytidine Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides Nucleosides Pyrimidine Nucleosides Pyrimidines
CAS number	951-77-9

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Thymidine kinase 2, mitochondrial	MLLWPLRGWAARALRCFGPGSRGSPASGPGPRRVQRRAWPPDKEQEKEKK...	unknown	substrate
Deoxycytidine kinase	MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEV...	unknown	substrate
Deoxycytidine kinase	MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEV...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682